VIH e o Advento da Imunoterapia no Tratamento do Doente Oncológico: O Caminho é a Inclusão

Fábio Videira Santos; Ana Lebre

doi:10.20344/amp.18032

HIV and the Advent of Immunotherapy in Cancer Treatment: The Path is Inclusion

Authors

Fábio Videira Santos Doenças Infeciosas. Departamento de Medicina. Instituto Português de Oncologia do Porto. Porto. https://orcid.org/0000-0002-9098-3412
Ana Lebre Doenças Infeciosas. Departamento de Medicina. Instituto Português de Oncologia do Porto. Porto. https://orcid.org/0000-0001-5184-0083

DOI:

https://doi.org/10.20344/amp.18032

Keywords:

HIV Infections, Immunotherapy, Neoplasms

Abstract

N/a.

Downloads

Download data is not yet available.

Author Biography

Fábio Videira Santos, Doenças Infeciosas. Departamento de Medicina. Instituto Português de Oncologia do Porto. Porto.

Assistente Hospitalar de Doenças Infecciosas

Downloads

PDF (Português)

Published

2022-07-01

How to Cite

Videira Santos F, Lebre A. HIV and the Advent of Immunotherapy in Cancer Treatment: The Path is Inclusion. Acta Med Port [Internet]. 2022 Jul. 1 [cited 2024 Nov. 12];35(7-8):608-9. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/18032

Download Citation

Issue

Vol. 35 No. 7-8 (2022): July-August

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.